A Phase 1 Study to Evaluate SNDX- 6352 in Subjects With Active cGVHD
about
A Phase 1 Study to Evaluate SNDX- 6352 in Subjects With Active cGVHD
description
clinical trial
@en
klinisch onderzoek
@nl
name
A Phase 1 Study to Evaluate SNDX- 6352 in Subjects With Active cGVHD
@en
type
label
A Phase 1 Study to Evaluate SNDX- 6352 in Subjects With Active cGVHD
@en
prefLabel
A Phase 1 Study to Evaluate SNDX- 6352 in Subjects With Active cGVHD
@en
P6153
P1476
A Phase 1, Open-Label, Dose Es ...... r Therapy, Including Ibrutinib
@en
P3098
NCT03604692
P580
2018-11-01T00:00:00Z
P582
2019-10-01T00:00:00Z